AFA
MRK icon

Abacus FCF Advisors’s Merck MRK Stock Holding History

Abacus FCF Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71,474
Closed -$5.66M – 77
2025
Q2 		$5.66M Buy
71,474
+1,225
+2% +$97.4K 0.79% 46
2025
Q1 		$6.31M Sell
70,249
-53,554
-43% -$5M 0.99% 36
2024
Q4 		$12.3M Buy
123,803
+78,938
+176% +$8.14M 1.62% 10
2024
Q3 		$5.09M Sell
44,865
-27,533
-38% -$3.27M 1.18% 21
2024
Q2 		$8.96M Buy
72,398
+7,846
+12% +$1.01M 2.23% 5
2024
Q1 		$8.52M Buy
64,552
+13,266
+26% +$1.64M 2.13% 5
2023
Q4 		$5.59M Buy
51,286
+32,490
+173% +$3.37M 1.62% 8
2023
Q3 		$1.94M Sell
18,796
-508
-3% -$54.8K 1.03% 22
2023
Q2 		$2.23M Buy
19,304
+4,815
+33% +$547K 1.12% 18
2023
Q1 		$1.54M Buy
14,489
+2,968
+26% +$320K 0.83% 37
2022
Q4 		$1.28M Buy
+11,521
New +$1.18M 0.83% 35
2022
Q2 		– Sell
-9,568
Closed -$785K – 161
2022
Q1 		$785K Buy
+9,568
New +$754K 0.26% 150
2020
Q2 		– Sell
-13,316
Closed -$911K – 87
2020
Q1 		$911K Sell
13,316
-1,358
-9% -$107K 1.04% 60
2019
Q4 		$1.28M Sell
14,674
-340
-2% -$27.9K 1.01% 55
2019
Q3 		$1.21M Buy
15,014
+35
+0.2% +$2.81K 1% 66
2019
Q2 		$1.2M Sell
14,979
-6,245
-29% -$478K 0.98% 59
2019
Q1 		$1.68M Buy
21,224
+1,012
+5% +$75.7K 1.3% 8
2018
Q4 		$1.47M Buy
+20,212
New +$1.43M 1.35% 4
2015
Q2 		– Sell
-38,608
Closed -$2.12M – 118
2015
Q1 		$2.12M Buy
+38,608
New +$2.19M 1.04% 81

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Abacus FCF Advisors's MRK Position: Q3 2025 in Review

Abacus FCF Advisors sold out of Merck (MRK) in Q3 2025, closing a stake of 71,474 shares — an estimated $5.66M sold.

Abacus FCF Advisors first reported a position in MRK in Q1 2015 and held it in 19 quarters. The position peaked at $12.3M in Q4 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Abacus FCF Advisors reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Abacus FCF Advisors sold 71,474 Merck shares in Q3 2025, an estimated $5.66M.
  • Abacus FCF Advisors first reported a position in Merck in Q1 2015 and held it in 19 quarters.
  • Abacus FCF Advisors's Merck position peaked at $12.3M in Q4 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Abacus FCF Advisors's 13F filing for Q3 2025, filed 20 Oct 2025.